Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501093 · ClinicalTrials.gov registry record
Diabetes Reversal and the Subgingival Microbiota
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 102
- Enrollment target
NCT05501093: Completed study, sponsored by University of Pennsylvania.
NCT05501093 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05501093 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. Participants will attend a screening and baseline visit prior to bariatric surgery and three post bariatric surgery appointments (3 weeks post, 6 months post and 1 year to 18 months post). Samples collected at each study visit include blood, plaque, and other oral samples. At the last study visit there is an optional dental cleaning.
Interventions
- OTHER sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05501093
The ClinicalTrials.gov registry entry for NCT05501093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sample collection is the first listed.
NCT05501093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05501093 about?
NCT05501093 is a clinical study titled "Diabetes Reversal and the Subgingival Microbiota". This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. P...
What is the current status of trial NCT05501093?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2019-03-11. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05501093?
The interventions under investigation include: sample collection (OTHER).
Who is sponsoring clinical trial NCT05501093?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.